Securing access to optimal cancer care for all patients can only be achieved through integrated, sustainable translation of today's scientific advances into tomorrow's treatments, reinforced by a clear understanding of the magnitude of clinical effects and accurate identification of patients most likely to benefit.
Checking the heartbeat of babies in the womb is set to become more accurate and less stressful for expectant mothers thanks to research by the University of Sussex.
Some European countries take more than twice as long as others to reach health technology assessment (HTA) decisions to reimburse new cancer drugs following their approval by the European Medicines Agency (EMA). The average decision time is longer than one year in some countries, according to a study to be reported at ESMO 2018 Congress.
Women with HER2-positive early breast cancer with small tumours have similar disease-free survival and lower risk of cardiac toxicity with a nine-week course of adjuvant trastuzumab compared to those treated for one year, according to a subgroup analysis of the Short-HER trial reported at ESMO 2018 Congress in Munich.
A recent Rutgers study finds that parents educated beyond high school have healthier families, as they invest more in family health care which reduces the likelihood of adverse medical conditions.
The new approach lets scientists examine the cumulative effect of multiple gene mutations, providing a much more complete picture of cancers' causes.
A new study shows wide variation in prescriptions of sedative drugs, called benzodiazepines, to people with Medicare coverage. Some counties, especially in southern and rural western states, had three times the level of sedative prescribing as others. The study also highlights gaps at the level of individual prescribers: Some primary care providers prescribed sedatives more than six times more often than their peers. These high-intensity prescribers also tended to be high-intensity prescribers of opioid painkillers.
Men and women may need to be treated differently -- at least when it comes to some types of cancer. In an analysis to be presented at the ESMO 2018 Congress in Munich, data was pooled from four UK randomised controlled clinical trials (RCTs) of first line chemotherapy in oesophagogastric (OG) cancer, finding significant differences in a number of important side-effects experienced by male and female patients.
Nearly one in six premenopausal women being treated for early stage breast cancer do not adhere adequately to tamoxifen therapy after one year of treatment, potentially putting themselves at increased risk of recurrence and reduced survival, a French prospective study reports at ESMO 2018.
'Primary health care is in crisis... Leadership after the Astana meeting is essential to rejuvenate and revitalise all aspects of primary health care.' -- The Lancet special issue on primary health care marks 40 years since landmark Alma-Ata Declaration.